B

Biosergen AB
STO:BIOSGN

Watchlist Manager
Biosergen AB
STO:BIOSGN
Watchlist
Price: 39.52 SEK -3.61%
Market Cap: 92.9m SEK

Wall Street
Price Targets

BIOSGN Price Targets Summary
Biosergen AB

Wall Street analysts forecast BIOSGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOSGN is 153 SEK with a low forecast of 151.5 SEK and a high forecast of 157.5 SEK.

Lowest
Price Target
151.5 SEK
283% Upside
Average
Price Target
153 SEK
287% Upside
Highest
Price Target
157.5 SEK
299% Upside
Biosergen AB Competitors:
Price Targets
CGON
CG Oncology Inc
76% Upside
688331
RemeGen Co Ltd
20% Upside
MDGL
Madrigal Pharmaceuticals Inc
5% Upside
MRUS
Merus NV
11% Upside
CCCC
C4 Therapeutics Inc
495% Upside
6855
Ascentage Pharma Group International
100% Upside
RCKT
Rocket Pharmaceuticals Inc
129% Upside
CPRX
Catalyst Pharmaceuticals Inc
51% Upside

Revenue
Forecast

Revenue Estimate
Biosergen AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biosergen AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biosergen AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOSGN's stock price target?
Price Target
153 SEK

According to Wall Street analysts, the average 1-year price target for BIOSGN is 153 SEK with a low forecast of 151.5 SEK and a high forecast of 157.5 SEK.

Back to Top